Oxcarbazepine Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Oxcarbazepine Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A22730
Buy Now

Oxcarbazepine Prices December 2023

Category Region Price
Oxcarbazepine Chemical India 118140 USD/MT

The price of oxcarbazepine in the India for Q4 2023 reached 118140 USD/MT in December. This significant price trend was mainly attributed to the rising demand for drugs containing oxcarbazepine, which was fueled by the start of winter in India. Additionally, the observed increase in prices was primarily caused by the growing need for oxcarbazepine, a medication that is essential in preventing blood clots. Moreover, retailers deliberately concentrated on replenishing orders in anticipation of the approaching holiday season to proactively reduce the possibility of shortages and delivery delays. Furthermore, this preemptive strategy attempted to meet the increased demand during the holiday season and guarantee a continuous supply chain. Customers were significantly impacted by the increase in oxcarbazepine prices on the supply side, particularly those who depend on generic medications due to weak health.

Oxcarbazepine Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Oxcarbazepine Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of oxcarbazepine pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of price trends across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing oxcarbazepine price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Oxcarbazepine Price Trend

Oxcarbazepine Market Analysis

The global oxcarbazepine market size reached US$ 100 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 161.9 Million, at a projected CAGR of 5.5% during 2023-2032.

  • The effectiveness of carbamazepine in treating bipolar disorder-related mood swings has been increasingly acknowledged. As per the reports by the Hopkins Medicine, Bipolar disorder, affects approximately 2.6% of Americans aged 18 and older each year -- the average age at onset for a first manic episode is during the early 20s. Its broader application to mood disorders in addition to epilepsy is driving market expansion. Moreover due to its comparatively mild side effect profile when compared to other mood stabilizers, doctors are prescribing oxcarbazepine more frequently as a preferred treatment option. This is contributing to the drug's adoption in new patient segments. Its growing application in a variety of clinical settings confirms its reputation as an adaptable and essential part of treatment programs for mental health issues.
  • Generic Oxcarbazepine is more widely available due to the increasing expiration of patents for the branded medication. Hence, the rising preference for generic drugs is also propelling the market. As per the National Institute of Health, 82% and 77% of patients were adherent to generic and branded drugs, respectively (P = 0.289). As expected, a significantly lower cost of generic drugs was observed compared to its branded counterpart. Manufacturers of generic drugs are taking advantage of this chance to seize and increase their market share, which is also beneficial in areas where healthcare spending is expensive. To set products apart in a crowded market, this move toward generics is also stimulating additional innovation in medication formulations and packaging.
  • The need for efficient and reasonably priced treatments for neurological diseases, such as epilepsy, is rising as emerging economies' healthcare systems advance. Epilepsy has become very common with time. Consequently, the demand for oxcarbazepine is rising in these areas due to its established efficacy and safety record. Pharma firms are concentrating on these markets to take advantage of fresh chances for expansion, customizing their approaches to fit regional legal and commercial frameworks. To raise awareness of the advantages and applications of oxcarbazepine, initiatives include collaborating with regional health authorities, carrying out clinical trials tailored to the needs of the area, and developing educational materials.

Oxcarbazepine News

The report covers the latest developments, updates, and trends impacting the global oxcarbazepine market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in oxcarbazepine production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.

Latest developments in the oxcarbazepine industry:

  • In January 2024, Camber Pharmaceuticals announced the addition of Oxcarbazepine Oral Suspension, USP to its current portfolio.  
  • In July, 2023, Zydus Lifesciences Limited announced that it had received final approval from the United States Food and Drug Administration (USFDA) for Oxcarbazepine Tablets USP, 150 mg, 300 mg and 600 mg (USRLD: Trileptal Tablets, 150 mg, 300 mg, and 600 mg).

Product Description

The main purpose of the anticonvulsant drug oxcarbazepine is to treat epilepsy-related seizures. It functions by bringing the brain's electrical activity under control and stopping the fast and erratic neuronal firing that leads to seizures. There are several ways to get oxcarbazepine, such as tablets and a liquid suspension. In addition, it can help stabilize mood when treating bipolar disorder. The medication is intended for both adult and pediatric use, and for maximum effectiveness, it may be prescribed either by itself or in conjunction with other drugs.

Chemical synthesis is used to create oxcarbazepine. In a regulated laboratory environment, precursor chemicals are converted into active compounds. The procedure usually consists of steps like formulation, purification, and synthesis. The last step involves creating an oral suspension or tablet form for oxcarbazepine. Strict regulatory guidelines are followed during this manufacturing process in pharmaceutical facilities to guarantee the drug's efficacy, safety, and quality.

Regional Coverage

The report provides a detailed analysis of the oxcarbazepine market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the price trends. 

Global Oxcarbazepine Price

The report offers a holistic view of the global oxcarbazepine pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

Europe Oxcarbazepine Price

In the European quarter of 2023, oxcarbazepine pricing patterns were almost the same as those in other importing regions—most notably, North America. Prices continued to rise until the last few weeks of December 2023. oxcarbazepine prices increased noticeably as a result of the ongoing improvement in buying sentiment in the domestic market.

This analysis can be extended to include detailed oxcarbazepine price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.

North America Oxcarbazepine Price

The pricing trends of oxcarbazepine API during the fourth quarter of 2023 were closely linked to the changing market conditions in the Asia-Pacific area. More broadly, prices showed an upward trend, which was mainly due to the steady and steady increase in downstream consumption in the area. One notable factor contributing to this ongoing upward trend was a gradual but steady improvement in downstream purchasing sentiment.

Specific data on oxcarbazepine prices within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada

Middle East and Africa Oxcarbazepine Price

The report explores the oxcarbazepine pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on oxcarbazepine prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.

Asia Pacific Oxcarbazepine Price

In the fourth quarter, the market expectations of oxcarbazepine in Asia Pacific countries, particularly in India, remained extremely vibrant. This optimistic view displays a tendency of price increase, that is, rising demand and creating favorable regulatory regimes. Stakeholders have underlined sustainable growth opportunities built on robust dynamics of markets and enlarging patients population. This pathway represents the pharmaceutical industries faith in the region's potential and calls attention to the options that can be utilized in order to infiltrate the market further and generate more revenue. Generally, the perspective is a meaningful landscape for oxcarbazepine and other stakeholders in Pacific Asia market for pharmaceutical industries.

This analysis can be further extended to include detailed oxcarbazepine prices for a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.

Latin America Oxcarbazepine Price

The analysis of oxcarbazepine prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.

Report Coverage

Key Attributes Details
Product Name Oxcarbazepine
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year  
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 

Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of oxcarbazepine pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting oxcarbazepine price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the oxcarbazepine industry.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Oxcarbazepine Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More